Targenomix, a spin-off of the Max Planck Institute for Molecular Plant Physiology, will contribute to Bayer’s Crop Science R&D pipeline by continuing to deliver novel systems biology approaches for innovative crop protection discovery / Targenomix…
Scientists have used a proteomics approach to identify a three-protein signature in the blood that can improve detection of impaired glucose tolerance, and help identify individuals at high risk of developing type 2 diabetes.
The Creative Destruction Lab (CDL) is one of the world’s most renowned startup accelerators for deep tech and will be launched for the first time in Germany this year - at ESMT Berlin with a focus on health.
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, SDAX) increased sales by 25% to EUR 164.0 million in the first nine months of 2022. Net income of EUR 23.3 million was EUR 5.8 million lower than in the same period of the previous…
Falling Walls Foundation awards Prof. Dr. Marcus Mall for his research
The Falling Walls Foundation has awarded Prof. Dr. Marcus Mall of Charité – Universitätsmedizin Berlin the title Science Breakthrough of the Year 2022 in Life Sciences for a new…
Study published in Nature identifies novel approaches for anti-allergic therapies
Inflammation and increased mucus production are typical symptoms of worm infections and allergies. This immune response involves our innate immune cells, but their…
Berlin/Aalborg, 27 October 2022. The University Hospital Aalborg (Denmark) yesterday has imaged the first patient with Eckert and Ziegler’s Gallium (68Ga) boclatixafortide (PENTIXAFOR) in an international phase 2 trial.
The IMAG1NE Phase 1/2 trial is an accelerated dose-titration, open-label, multi-center Phase 1/2 trial to evaluate TK-8001 in patients with MAGE-A1 positive solid tumors
TK-8001 targets a MAGE-A1 epitope presented on HLA-A*02:01
IMAG1NE…
Berlin, Germany and Stockholm, Sweden, October 20, 2022:
FyoniBio, a CDO expert specialized in tailored cell line development and Strike Pharma, whose proprietary
Adaptable Drug Affinity Conjugate (ADAC) technology enables development of …
As a consortium partner of the DAKI-FWS project, Data4Life contributes to the early detection of future pandemics and natural disasters
With DAKI Health, the German population can actively participate in the research project by donating…
